Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron

Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial (2019) Van Der Worp HB, Macleod MR, Bath PMW, Bathula R, Christensen H, Colam B, Cordonnier C, et al. Journal article Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke (2019) Alexandrov AV, Tsivgoulis G, Köhrmann M, Katsanos AH, Soinne L, Barreto AD, Rothlisberger T, et al. Journal article GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE (2019) Wong L, Mescia F, Alberici F, Ball MJ, Baslund B, Brenchley P, Bruchfeld A, et al. Conference contribution Immunological methods for diagnosis and monitoring of IgE-mediated allergy caused by industrial sensitizing agents (IMExAllergy) (2019) Baur X, Akdis CA, Budnik LT, Cruz MJ, Fischer A, Förster-Ruhrmann U, Göen T, et al. Journal article, Review article Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms (2019) Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, Krejs GJ, et al. Journal article Immunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment (2018) Belaloui K, Malifarge E, Bohm J, Bossard C, Dienstmann R, Garcia S, Geppert CI, et al. Conference contribution Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease. (2018) Burgmaier K, Kunzmann K, Ariceta G, Bergmann C, Buescher AK, Burgmaier M, Dursun I, et al. Journal article TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study (2018) De Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, et al. Journal article Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data (2018) Al-Shahi Salman R, Frantzias J, Lee RJ, Battey TW, Ayres AM, Goldstein JN, Mayer SA, et al. Journal article Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial (2018) Hurvitz SA, Quek RGW, Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, et al. Journal article